{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T19:58:00Z","timestamp":1775159880579,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T00:00:00Z","timestamp":1709078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T00:00:00Z","timestamp":1709078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-024-02950-x","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T17:02:29Z","timestamp":1709139749000},"page":"691-698","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Is a minimum duration of 5 days of unfractionated heparin infusion necessary before transition to oral anticoagulation in cerebral venous thrombosis? a retrospective chart review"],"prefix":"10.1007","volume":"57","author":[{"given":"Ariel N.","family":"Carrion","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa A.","family":"Allison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2544-900X","authenticated-orcid":false,"given":"Sophie","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,28]]},"reference":[{"key":"2950_CR1","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1161\/STR.0b013e31820a8364","volume":"42","author":"G Saposnik","year":"2011","unstructured":"Saposnik G, Barinagarrementeria F, Brown RD et al (2011) Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 42:1158\u20131192. https:\/\/doi.org\/10.1161\/STR.0b013e31820a8364","journal-title":"Stroke"},{"key":"2950_CR2","doi-asserted-by":"crossref","unstructured":"Stam J (2005) Thrombosis of the Cerebral Veins and Sinuses","DOI":"10.1056\/NEJMra042354"},{"key":"2950_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/159101990200800102","volume":"8","author":"S-K Lee","year":"2002","unstructured":"Lee S-K, Kim B-S, terBrugge KG (2002) Clinical presentation, imaging and treatment of cerebral venous thrombosis (CVT). Interventional Neuroradiol 8:5\u201314. https:\/\/doi.org\/10.1177\/159101990200800102","journal-title":"Interventional Neuroradiol"},{"key":"2950_CR4","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1161\/CIRCULATIONAHA.111.067835","volume":"125","author":"G Piazza","year":"2012","unstructured":"Piazza G (2012) Cerebral venous thrombosis. Circulation 125:1704\u20131709. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.067835","journal-title":"Circulation"},{"key":"2950_CR5","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1161\/01.STR.0000117571.76197.26","volume":"35","author":"JM Ferro","year":"2004","unstructured":"Ferro JM, Canh\u00e3o P, Stam J et al (2004) Prognosis of cerebral vein and Dural Sinus thrombosis. Stroke 35:664\u2013670. https:\/\/doi.org\/10.1161\/01.STR.0000117571.76197.26","journal-title":"Stroke"},{"key":"2950_CR6","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1161\/01.STR.0000177894.05495.54","volume":"36","author":"JM Ferro","year":"2005","unstructured":"Ferro JM, Canh\u00e3o P, Bousser M-G et al (2005) Cerebral vein and Dural Sinus thrombosis in Elderly patients. Stroke 36:1927\u20131932. https:\/\/doi.org\/10.1161\/01.STR.0000177894.05495.54","journal-title":"Stroke"},{"key":"2950_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1159\/000111259","volume-title":"Handbook on cerebral venous thrombosis","author":"GR de Freitas","year":"2007","unstructured":"de Freitas GR, Bogousslavsky J (2007) Risk factors of cerebral vein and sinus thrombosis. Handbook on cerebral venous thrombosis. KARGER, Basel, pp 23\u201354"},{"key":"2950_CR8","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1161\/STROKEAHA.117.019483","volume":"49","author":"SM Zuurbier","year":"2018","unstructured":"Zuurbier SM, Hiltunen S, Lindgren E et al (2018) Cerebral venous thrombosis in older patients. Stroke 49:197\u2013200. https:\/\/doi.org\/10.1161\/STROKEAHA.117.019483","journal-title":"Stroke"},{"key":"2950_CR9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1161\/01.STR.16.2.199","volume":"16","author":"MG Bousser","year":"1985","unstructured":"Bousser MG, Chiras J, Bories J, Castaigne P (1985) Cerebral venous thrombosis\u2013a review of 38 cases. Stroke 16:199\u2013213. https:\/\/doi.org\/10.1161\/01.STR.16.2.199","journal-title":"Stroke"},{"key":"2950_CR10","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1161\/STROKEAHA.107.512814","volume":"39","author":"BA Khealani","year":"2008","unstructured":"Khealani BA, Wasay M, Saadah M et al (2008) Cerebral venous thrombosis. Stroke 39:2707\u20132711. https:\/\/doi.org\/10.1161\/STROKEAHA.107.512814","journal-title":"Stroke"},{"key":"2950_CR11","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1136\/jnnp.2004.056275","volume":"76","author":"R Cumurciuc","year":"2005","unstructured":"Cumurciuc R (2005) Headache as the only neurological sign of cerebral venous thrombosis: a series of 17 cases. J Neurol Neurosurg Psychiatry 76:1084\u20131087. https:\/\/doi.org\/10.1136\/jnnp.2004.056275","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2950_CR12","doi-asserted-by":"publisher","first-page":"e20900","DOI":"10.1097\/MD.0000000000020900","volume":"99","author":"D Garc\u00eda-Azor\u00edn","year":"2020","unstructured":"Garc\u00eda-Azor\u00edn D, Monje MHG, Gonz\u00e1lez-Garc\u00eda N et al (2020) Presence of red flags in patients with cerebral venous sinus thrombosis admitted to the emergency department because of headache: a STROBE compliant cohort-study. Medicine 99:e20900. https:\/\/doi.org\/10.1097\/MD.0000000000020900","journal-title":"Medicine"},{"key":"2950_CR13","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.clineuro.2004.10.004","volume":"107","author":"S Appenzeller","year":"2005","unstructured":"Appenzeller S, Zeller CB, Annichino-Bizzachi JM et al (2005) Cerebral venous thrombosis: influence of risk factors and imaging findings on prognosis. Clin Neurol Neurosurg 107:371\u2013378. https:\/\/doi.org\/10.1016\/j.clineuro.2004.10.004","journal-title":"Clin Neurol Neurosurg"},{"key":"2950_CR14","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1212\/WNL.53.7.1537","volume":"53","author":"V Biousse","year":"1999","unstructured":"Biousse V, Ameri A, Bousser M-G (1999) Isolated intracranial hypertension as the only sign of cerebral venous thrombosis. Neurology 53:1537\u20131537. https:\/\/doi.org\/10.1212\/WNL.53.7.1537","journal-title":"Neurology"},{"key":"2950_CR15","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1212\/01.wnl.0000179677.84785.63","volume":"65","author":"WM van den Bergh","year":"2005","unstructured":"van den Bergh WM, van der Schaaf I, van Gijn J (2005) The spectrum of presentations of venous infarction caused by deep cerebral vein thrombosis. Neurology 65:192\u2013196. https:\/\/doi.org\/10.1212\/01.wnl.0000179677.84785.63","journal-title":"Neurology"},{"key":"2950_CR16","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1111\/ene.13381","volume":"24","author":"JM Ferro","year":"2017","unstructured":"Ferro JM, Bousser M-G, Canh\u00e3o P et al (2017) European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis \u2013 endorsed by the European Academy of Neurology. Eur J Neurol 24:1203\u20131213. https:\/\/doi.org\/10.1111\/ene.13381","journal-title":"Eur J Neurol"},{"key":"2950_CR17","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1148\/rg.26si055174","volume":"26","author":"JL Leach","year":"2006","unstructured":"Leach JL, Fortuna RB, Jones BV, Gaskill-Shipley MF (2006) Imaging of cerebral venous thrombosis: current techniques, Spectrum of findings, and Diagnostic pitfalls. Radiographics 26:S19\u2013S41. https:\/\/doi.org\/10.1148\/rg.26si055174","journal-title":"Radiographics"},{"key":"2950_CR18","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/j.1600-0404.2006.00595.x","volume":"114","author":"A Sagduyu","year":"2006","unstructured":"Sagduyu A, Sirin H, Mulayim S et al (2006) Cerebral cortical and deep venous thrombosis without sinus thrombosis: clinical MRI correlates. Acta Neurol Scand 114:254\u2013260. https:\/\/doi.org\/10.1111\/j.1600-0404.2006.00595.x","journal-title":"Acta Neurol Scand"},{"key":"2950_CR19","first-page":"539","volume":"2","author":"K Ford","year":"1981","unstructured":"Ford K, Sarwar M (1981) Computed tomography of dural sinus thrombosis. AJNR Am J Neuroradiol 2:539\u2013543","journal-title":"AJNR Am J Neuroradiol"},{"key":"2950_CR20","first-page":"1021","volume":"16","author":"FY Tsai","year":"1995","unstructured":"Tsai FY, Wang AM, Matovich VB et al (1995) MR staging of acute dural sinus thrombosis: correlation with venous pressure measurements and implications for treatment and prognosis. AJNR Am J Neuroradiol 16:1021\u20131029","journal-title":"AJNR Am J Neuroradiol"},{"key":"2950_CR21","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/s1052-5149(02)00095-3","volume":"13","author":"S-K Lee","year":"2003","unstructured":"Lee S-K, terBrugge KG (2003) Cerebral venous thrombosis in adults: the role of imaging evaluation and management. Neuroimaging Clin N Am 13:139\u2013152. https:\/\/doi.org\/10.1016\/s1052-5149(02)00095-3","journal-title":"Neuroimaging Clin N Am"},{"key":"2950_CR22","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.2214\/AJR.05.1249","volume":"187","author":"N Khandelwal","year":"2006","unstructured":"Khandelwal N, Agarwal A, Kochhar R et al (2006) Comparison of CT venography with MR Venography in cerebral sinovenous thrombosis. AJR Am J Roentgenol 187:1637\u20131643. https:\/\/doi.org\/10.2214\/AJR.05.1249","journal-title":"AJR Am J Roentgenol"},{"key":"2950_CR23","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s00270-007-9046-1","volume":"30","author":"FY Tsai","year":"2007","unstructured":"Tsai FY, Kostanian V, Rivera M et al (2007) Cerebral venous congestion as indication for thrombolytic treatment. Cardiovasc Intervent Radiol 30:675\u2013687. https:\/\/doi.org\/10.1007\/s00270-007-9046-1","journal-title":"Cardiovasc Intervent Radiol"},{"key":"2950_CR24","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1161\/01.str.30.3.484","volume":"30","author":"SF de Bruijn","year":"1999","unstructured":"de Bruijn SF, Stam J (1999) Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke 30:484\u2013488. https:\/\/doi.org\/10.1161\/01.str.30.3.484","journal-title":"Stroke"},{"key":"2950_CR25","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/j.1600-0404.1992.tb05106.x","volume":"86","author":"JM Diaz","year":"1992","unstructured":"Diaz JM, Schiffman JS, Urban ES, Maccario M (1992) Superior sagittal sinus thrombosis and pulmonary embolism: a syndrome rediscovered. Acta Neurol Scand 86:390\u2013396. https:\/\/doi.org\/10.1111\/j.1600-0404.1992.tb05106.x","journal-title":"Acta Neurol Scand"},{"key":"2950_CR26","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/nrneurol.2017.104","volume":"13","author":"SM Silvis","year":"2017","unstructured":"Silvis SM, de Sousa DA, Ferro JM, Coutinho JM (2017) Cerebral venous thrombosis. Nat Rev Neurol 13:555\u2013565. https:\/\/doi.org\/10.1038\/nrneurol.2017.104","journal-title":"Nat Rev Neurol"},{"key":"2950_CR27","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s11910-019-0988-x","volume":"19","author":"JM Ferro","year":"2019","unstructured":"Ferro JM, Aguiar de Sousa D (2019) Cerebral venous thrombosis: an update. Curr Neurol Neurosci Rep 19:74. https:\/\/doi.org\/10.1007\/s11910-019-0988-x","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2950_CR28","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/0140-6736(91)90607-q","volume":"338","author":"KM Einh\u00e4upl","year":"1991","unstructured":"Einh\u00e4upl KM, Villringer A, Meister W et al (1991) Heparin treatment in sinus venous thrombosis. Lancet 338:597\u2013600. https:\/\/doi.org\/10.1016\/0140-6736(91)90607-q","journal-title":"Lancet"},{"key":"2950_CR29","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1001\/jamaneurol.2019.2764","volume":"76","author":"JM Ferro","year":"2019","unstructured":"Ferro JM, Coutinho JM, Dentali F et al (2019) Safety and Efficacy of Dabigatran Etexilate vs dose-adjusted warfarin in patients with cerebral venous thrombosis: a Randomized Clinical Trial. JAMA Neurol 76:1457\u20131465. https:\/\/doi.org\/10.1001\/jamaneurol.2019.2764","journal-title":"JAMA Neurol"},{"key":"2950_CR30","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1161\/STROKEAHA.121.037541","volume":"53","author":"S Yaghi","year":"2022","unstructured":"Yaghi S, Shu L, Bakradze E et al (2022) Direct oral anticoagulants Versus Warfarin in the treatment of cerebral venous thrombosis (ACTION-CVT): a Multicenter International Study. Stroke 53:728\u2013738. https:\/\/doi.org\/10.1161\/STROKEAHA.121.037541","journal-title":"Stroke"},{"key":"2950_CR31","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1161\/STROKEAHA.107.181486","volume":"38","author":"HP Adams","year":"2007","unstructured":"Adams HP, del Zoppo G, Alberts MJ et al (2007) Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association\/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the atherosclerotic peripheral vascular disease and quality of Care outcomes in Research Interdisciplinary Working groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 38:1655\u20131711. https:\/\/doi.org\/10.1161\/STROKEAHA.107.181486","journal-title":"Stroke"},{"key":"2950_CR32","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1161\/STROKEAHA.116.015434","volume":"48","author":"P Lyden","year":"2017","unstructured":"Lyden P (2017) Using the National Institutes of Health Stroke Scale: a cautionary tale. Stroke 48:513\u2013519. https:\/\/doi.org\/10.1161\/STROKEAHA.116.015434","journal-title":"Stroke"},{"key":"2950_CR33","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1161\/01.STR.0000258355.23810.c6","volume":"38","author":"JL Banks","year":"2007","unstructured":"Banks JL, Marotta CA (2007) Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis. Stroke 38:1091\u20131096. https:\/\/doi.org\/10.1161\/01.STR.0000258355.23810.c6","journal-title":"Stroke"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-024-02950-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-024-02950-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-024-02950-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T12:08:19Z","timestamp":1713442099000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-024-02950-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,28]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["2950"],"URL":"https:\/\/doi.org\/10.1007\/s11239-024-02950-x","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,28]]},"assertion":[{"value":"14 January 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ariel N.\u00a0Carrion, Teresa A.\u00a0Allison, and Sophie Samuel, declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}